Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
OTL38 for Injection
DRUG
2 trials
Sponsors
On Target Laboratories, LLC
Conditions
Lung Cancer
Lung Neoplasms
Phase 2
OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Completed
NCT02872701
On Target Laboratories, LLC
Lung Cancer, Lung Neoplasms
Start: 2017-05-04
End: 2018-11-30
Updated: 2023-03-24
Phase 3
ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
Completed
NCT04241315
On Target Laboratories, LLC
Lung Cancer, Lung Neoplasms
Start: 2020-03-26
End: 2021-11-01
Updated: 2023-03-23
Related Papers
Intraoperative Molecular Imaging With Pafolacianine in Resection of Occult Pulmonary Malignancy in the ELUCIDATE Trial.
2024-10-21
2 citations
An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas.
2018-02-05
29 citations